NCT06212180

Brief Summary

A sub-nasal mask with a skirt that fits the nostrils and with a dedicated port for the nasogastric tube has recently been introduced. This interface has never been compared to nasal-oral masks. We hypothesise that such a sub-nasal mask increases comfort compared to a conventional naso-oral mask. The primary objective is to compare the comfort of the sub-nasal mask with that of a standard naso-oral mask.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2024

Shorter than P25 for all trials

Geographic Reach
1 country

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2024

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

January 8, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

January 18, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

January 18, 2024

Status Verified

December 1, 2023

Enrollment Period

9 months

First QC Date

January 8, 2024

Last Update Submit

January 8, 2024

Conditions

Keywords

Non-invasive ventilationAcute respiratory failureComfort

Outcome Measures

Primary Outcomes (1)

  • 1 to 10 self assessment scale

    Comfort will be assessed by a numerical self-assessment scale from 0 to 10.

    throughout the study (an average of 10 months)

Secondary Outcomes (5)

  • Percentage of subjects who prefer one type of mask over the other

    throughout the study (an average of 10 months)

  • Percentage of leakage volume compared to the tidal leakage volume

    throughout the study (an average of 10 months)

  • Dyspnea

    throughout the study (an average of 10 months)

  • Number of interventions on mask position by nurses during NIV session

    throughout the study (an average of 10 months)

  • Number of side effects

    throughout the study (an average of 10 months)

Interventions

maskDEVICE

patients will be their own comparator. Patients will try both mask for 10 min and then decide which mask they want for the rest of the ventilation

Also known as: oronasal mask or subnasal mask

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adult patients hospitalized in intensive care, continuous monitoring unit or pulmonary intensive care with an indication for NIV.

You may qualify if:

  • Indication of NIV, carried out by the physicians in charge of the patient, among the following:
  • COPD exacerbation
  • Hydrostatic acute pulmonary edema
  • Acute Chest Syndrome with Hypercapnia in Sickle Cell Patients
  • Post-extubation, planned in a patient at risk or recovering from extubation failure
  • Hypoventilation-obesity syndrome

You may not qualify if:

  • Formal contraindication to NIV among:
  • Indication for orotracheal intubation at the outset
  • Non-cooperative, agitated, opponent of the technique
  • Coma
  • Respiratory exhaustion
  • Shock, severe ventricular arrhythmias, immediate aftermath of cardiac arrest
  • Undrained pneumothorax, blowing chest wound
  • Upper airway obstruction (except sleep apnea, laryngotracheomalacia)
  • Uncontrollable vomiting
  • Upper gastrointestinal bleeding
  • Measure of protection of justice
  • Facial deformity
  • Dying or palliative care patient
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Hôpital Henri Mondor - Réanimation/ Unité de Surveillance Continue

Créteil, France

Location

CHU Bicêtre - Unité de Soins Intensifs Pneumologique

Le Kremlin-Bicêtre, 94270, France

Location

CHU Bicêtre - USC

Le Kremlin-Bicêtre, 94270, France

Location

MeSH Terms

Conditions

HypercapniaObesity Hypoventilation Syndrome

Interventions

Masks

Condition Hierarchy (Ancestors)

Signs and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsSleep Apnea, ObstructiveSleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesHypoventilationRespiratory InsufficiencySleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Surgical AttireEquipment and Supplies, HospitalEquipment and SuppliesProtective DevicesPersonal Protective EquipmentSurgical EquipmentManufactured MaterialsTechnology, Industry, and Agriculture

Study Officials

  • Christophe CARPENTIER, MD

    Assistance Publique - Hôpitaux de Paris, Hôpital Bicêtre

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Christophe CARPENTIER, MD

CONTACT

Tai PHAM, MD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 8, 2024

First Posted

January 18, 2024

Study Start

January 1, 2024

Primary Completion

October 1, 2024

Study Completion

December 1, 2024

Last Updated

January 18, 2024

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations